513 related articles for article (PubMed ID: 20212226)
1. Primary central nervous system lymphoma.
Gerstner ER; Batchelor TT
Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
[TBL] [Abstract][Full Text] [Related]
2. Primary CNS lymphoma in immunocompetent patients.
Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
[TBL] [Abstract][Full Text] [Related]
3. Primary CNS lymphoma.
Gerstner E; Batchelor T
Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
[TBL] [Abstract][Full Text] [Related]
4. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
Monjour A; Poisson M; Kujas M; Delattre JY
Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
[TBL] [Abstract][Full Text] [Related]
5. [Primary central nervous system lymphomas].
Hrudková M; Belada D; Smolej L; Zák P; Malý J
Vnitr Lek; 2010 Aug; 56(8):795-800. PubMed ID: 20845611
[TBL] [Abstract][Full Text] [Related]
6. Primary CNS lymphoma.
Maher EA; Fine HA
Semin Oncol; 1999 Jun; 26(3):346-56. PubMed ID: 10375091
[TBL] [Abstract][Full Text] [Related]
7. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
8. Primary CNS lymphoma.
Batchelor T; Loeffler JS
J Clin Oncol; 2006 Mar; 24(8):1281-8. PubMed ID: 16525183
[TBL] [Abstract][Full Text] [Related]
9. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG
Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma.
Mohile NA; Abrey LE
Semin Radiat Oncol; 2007 Jul; 17(3):223-9. PubMed ID: 17591569
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
Bierman P; Giglio P
Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma: overview of current treatment strategies.
Brastianos PK; Batchelor TT
Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
[TBL] [Abstract][Full Text] [Related]
16. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma.
Batchelor TT
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):379-385. PubMed ID: 27913504
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for primary central nervous system lymphoma: a case-control study.
Schiff D; Suman VJ; Yang P; Rocca WA; O'Neill BP
Cancer; 1998 Mar; 82(5):975-82. PubMed ID: 9486590
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS Lymphoma.
Grommes C; DeAngelis LM
J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of primary central nervous system lymphoma.
Han CH; Batchelor TT
Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
